Drug Type Biological products |
Synonyms |
Target |
Action inhibitors |
Mechanism NRAS inhibitors(GTPase NRas inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | South Korea | 03 Dec 2021 | |
Colonic Cancer | IND Application | South Korea | 30 Jul 2024 | |
Melanoma | IND Application | South Korea | 30 Jul 2024 | |
Triple Negative Breast Cancer | IND Application | South Korea | 30 Jul 2024 |